Pfizer reports Q2 2026 revenue of $15.03B beating $14.41B estimate, raises 2026 revenue guidance midpoint, and maintains full-year adjusted EPS guidance of $2.80–$3.00.
LiveSquawk08/04, 06:11 PM
- Rev. $15.03B
- est $14.41B
- Prevnar Franchise Rev $1.34B
- est $1.38B
Figures as quoted by LiveSquawk
Related assets
Coming up for PFE
Explore next
Latest PFE news
Jin1008/04, 08:22 PM
ZeroHedge08/04, 05:45 PM
Pfizer raises full-year revenue guidance to $60.5B–$62.5B from prior $59.5B–$62.5B.
Finnhub07/25, 07:35 PM
Pfizer trades at a 6.8% dividend yield, significantly above the market average of roughly 1%.